Jan Rasmussen

464 total citations
19 papers, 294 citations indexed

About

Jan Rasmussen is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Jan Rasmussen has authored 19 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Clinical Biochemistry and 5 papers in Physiology. Recurrent topics in Jan Rasmussen's work include Mitochondrial Function and Pathology (12 papers), Metabolism and Genetic Disorders (12 papers) and Neonatal Health and Biochemistry (4 papers). Jan Rasmussen is often cited by papers focused on Mitochondrial Function and Pathology (12 papers), Metabolism and Genetic Disorders (12 papers) and Neonatal Health and Biochemistry (4 papers). Jan Rasmussen collaborates with scholars based in Denmark, Faroe Islands and Germany. Jan Rasmussen's co-authors include Allan M. Lund, Olav Wendelboe Nielsen, Lars Køber, Ulrike Steuerwald, Morten Dunø, Nils Janzen, Magni Mohr, David M. Hougaard, Kasper Kyhl and Gitte Hedermann and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and European Heart Journal.

In The Last Decade

Jan Rasmussen

19 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Rasmussen Denmark 12 200 193 64 53 46 19 294
Lisa A. Ford United States 9 37 0.2× 133 0.7× 55 0.9× 12 0.2× 25 0.5× 12 273
D. Batlle United States 3 25 0.1× 179 0.9× 48 0.8× 9 0.2× 45 1.0× 5 308
Carlos Robles-Valdés Mexico 7 263 1.3× 208 1.1× 193 3.0× 20 0.4× 29 0.6× 11 465
C. Rössle Germany 11 162 0.8× 52 0.3× 124 1.9× 11 0.2× 40 0.9× 28 395
Kelli D. Goodman United States 6 35 0.2× 112 0.6× 52 0.8× 9 0.2× 22 0.5× 9 218
Barbara Guisan Switzerland 6 37 0.2× 124 0.6× 9 0.1× 30 0.6× 19 0.4× 7 311
Maria Buch United States 7 186 0.9× 81 0.4× 50 0.8× 32 0.6× 94 2.0× 11 326
P. Wachtler Germany 7 31 0.2× 42 0.2× 218 3.4× 10 0.2× 15 0.3× 8 597
Raashda A. Sulaiman Saudi Arabia 9 40 0.2× 29 0.2× 72 1.1× 15 0.3× 8 0.2× 27 178
Jacquelyn M. Walejko United States 10 20 0.1× 136 0.7× 103 1.6× 5 0.1× 67 1.5× 12 269

Countries citing papers authored by Jan Rasmussen

Since Specialization
Citations

This map shows the geographic impact of Jan Rasmussen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Rasmussen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Rasmussen more than expected).

Fields of papers citing papers by Jan Rasmussen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Rasmussen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Rasmussen. The network helps show where Jan Rasmussen may publish in the future.

Co-authorship network of co-authors of Jan Rasmussen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Rasmussen. A scholar is included among the top collaborators of Jan Rasmussen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Rasmussen. Jan Rasmussen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
3.
Grove, Erik Lerkevang, et al.. (2022). Feasibility and impact of whole-body high-intensity interval training in patients with stable coronary artery disease: a randomised controlled trial. Scientific Reports. 12(1). 17295–17295. 11 indexed citations
4.
Grove, Erik Lerkevang, et al.. (2022). Haemostasis and fibrinolysis after regular high-intensity interval training in patients with coronary artery disease: a randomised controlled trial. Open Heart. 9(2). e002127–e002127. 5 indexed citations
5.
Grove, Erik Lerkevang, et al.. (2022). Effect of supervised high-intensity interval training on haemostasis in patients with coronary artery disease: a randomised controlled trial. European Heart Journal. 43(Supplement_2). 1 indexed citations
6.
Kyhl, Kasper, Allan M. Lund, Niels Vejlstrup, et al.. (2019). Cardiac function and incidence of unexplained myocardial scarring in patients with primary carnitine deficiency - a cardiac magnetic resonance study. Scientific Reports. 9(1). 13909–13909. 2 indexed citations
7.
Kyhl, Kasper, et al.. (2019). Knowledge about heart failure and self-care persists following outpatient programme- a prospective cohort study from the Faroe Islands. International Journal of Circumpolar Health. 78(1). 1653139–1653139. 11 indexed citations
8.
Rasmussen, Jan, Morten Dunø, Allan M. Lund, et al.. (2019). Increased risk of sudden death in untreated primary carnitine deficiency. Journal of Inherited Metabolic Disease. 43(2). 290–296. 23 indexed citations
9.
Madsen, Karen L., Nicolai Preisler, Jan Rasmussen, et al.. (2018). L-Carnitine Improves Skeletal Muscle Fat Oxidation in Primary Carnitine Deficiency. The Journal of Clinical Endocrinology & Metabolism. 103(12). 4580–4588. 17 indexed citations
10.
Rasmussen, Jan, et al.. (2017). Primary Carnitine Deficiency: Is Foetal Development Affected and Can Newborn Screening Be Improved?. JIMD Reports. 36. 35–40. 11 indexed citations
11.
Steuerwald, Ulrike, Allan M. Lund, Jan Rasmussen, et al.. (2017). Neonatal Screening for Primary Carnitine Deficiency: Lessons Learned from the Faroe Islands. International Journal of Neonatal Screening. 3(1). 1–1. 10 indexed citations
12.
Rasmussen, Jan, Allan M. Lund, Lotte Risom, et al.. (2014). Residual OCTN2 transporter activity, carnitine levels and symptoms correlate in patients with primary carnitine deficiency. Molecular Genetics and Metabolism Reports. 1. 241–248. 19 indexed citations
14.
Lund, Allan M., et al.. (2014). Is l-Carnitine Supplementation Beneficial in 3-Methylcrotonyl-CoA Carboxylase Deficiency?. JIMD Reports. 21. 79–88. 11 indexed citations
15.
Rasmussen, Jan, Olav Wendelboe Nielsen, Nils Janzen, et al.. (2013). Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. Journal of Inherited Metabolic Disease. 37(2). 215–222. 64 indexed citations
16.
Rasmussen, Jan, Lars Køber, Allan M. Lund, & Olav Wendelboe Nielsen. (2013). Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening. Journal of Inherited Metabolic Disease. 37(2). 223–230. 27 indexed citations
17.
Rasmussen, Jan, et al.. (2012). Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events. Journal of Inherited Metabolic Disease. 36(1). 35–41. 41 indexed citations
18.
19.
Rasmussen, Jan, et al.. (1982). The haematological and biochemical pattern in occupational organic solvent poisoning and exposure. International Archives of Occupational and Environmental Health. 51(2). 113–126. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026